Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 3, 2010, Pages e85-e90

  Gonzalez Vicent, Marta ^a   Perez, Antonio ^a   Abad, Lorea ^a   Sevilla, Julian ^a   Ramirez, Manuel ^a   Diaz, Miguel A ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

CD3 CD19 depletion; CD34+ selection; Children; Haploidentical transplantation; Leukemia

Indexed keywords

CD19 ANTIBODY; CD3 ANTIGEN; CD34 ANTIBODY; FLUDARABINE;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW CELL; CELL COUNT; CHILD; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DONOR; ENGRAFTMENT; FEMALE; GENETIC ENGINEERING; GRAFT MANIPULATION; GRAFT VERSUS HOST REACTION; HAPLOIDY; HUMAN; HUMAN CELL; KINETICS; LEUKEMIA; MALE; MORTALITY; NATURAL KILLER CELL; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; RELAPSE; SCHOOL CHILD;

ADOLESCENT; ANTIGENS, CD19; ANTIGENS, CD3; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE COUNT; MALE; MYELOABLATIVE AGONISTS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDIES; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VIDARABINE;

EID: 77951094193     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181cf813c     Document Type: Article

References (16)

1. Satwani P, Harrison L, Morris E, et al. Reduced-Intensity allogeneic stem cell transplantation in adults and children with malignant and non-malignant diseases: End of the beginning and futures challenges. BBMT. 2005;11: 403-422.
2. Urbano-Izpizua A, Brunet S, Solano C, et al. Allogeneic transplantation of CD34+ selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation. Bone Marrow Transplant. 2001;28: 349-354.
3. Bethge WA, Haegele M, Faul C, et al. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: Fast engraftment and low toxicity. Exp Hematol. 2006;34: 1746-1752.
4. Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cell from related donors with one fully mismatched HLA haplotype. N Engl J Med. 1998;339: 1186-1193.
5. Diaz MA, Sevilla J, de la Rubia J, et al. Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation. Haematologica. 2003;88: 919-922.
6. de la Rubia J, Diaz MA, Verdeguer A, et al. Donor age-related differences in PBPC mobilization with rHuG-CSF. Transfusion. 2001;41: 201-205.
7. Lassaletta A, Ramirez M, Montero JM, et al. Full donor chimerism by day 30 after allogeneic peripheral blood progenitor cell transplantation is associated with a low risk of relapse in pediatric patients with haematological malignancies. Leukemia. 2005;19: 504-506.
8. Perez A, Gonzalez-Vicent M, Ramirez M, et al. Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients. Br J Haematol. 2008;140: 340-343.
9. Diaz MA, Gonzalez-Vicent M, Gonzalez ME et at. Long-term outcome of allogeneic PBSC transplantation in pediatric patients with haematological malignancies: a report of the Spanish Working Party for Blood and Marrow Transplanattion in Children (GETMON) and Spanish Group for Allogeneic Peripheral Blood Transplantation (GETH). Bone Marrow Transplant. 2005;36: 781-785.
10. Lang P, Handgretinger R, Niethammer D, et al. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia. Blood. 2003;101: 1630-1636.
11. Aversa F, Terenzi A, Tabilio A, et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol. 2005;23: 3447-3454.
12. Watanabe T, Takaue Y, Kawano Y, et al. HLA-identical sibling peripheral blood stem cell transplantation in children and adolescents. BBMT. 2002;8: 26-31.
13. Thiede C, Bornhäuser M, Oelschlägel U, et al. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation using multiplex PCR amplification of short tandem repeat-markers. Leukemia. 2001;15: 293-302.
14. Woolfrey AE, Anasetti C, Storer B, et al. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. Blood. 2002;99: 2002-2008.
15. Lang P, Schumm M, Greil J, et al. A comparison between three graft manipulation methods for haploidentical stem cell transplantation in peditric patients: preliminary results of a pilot study. Klin Padiatr. 2005;217: 334-338.
16. Lang P, Greil J, Bader P, et al. Long-term outcome after haploidentical stem cell transplantation in children. Blood Cells Molecule Dis. 2004;33: 281-287.